nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP2D6—Sorafenib—liver cancer	0.0724	0.38	CbGbCtD
Oxymorphone—CYP3A4—Sorafenib—liver cancer	0.046	0.242	CbGbCtD
Oxymorphone—CYP2D6—Doxorubicin—liver cancer	0.0439	0.231	CbGbCtD
Oxymorphone—CYP3A4—Doxorubicin—liver cancer	0.0279	0.147	CbGbCtD
Oxymorphone—Respiratory distress—Sorafenib—liver cancer	0.0251	0.0365	CcSEcCtD
Oxymorphone—Drug interaction—Sorafenib—liver cancer	0.0172	0.025	CcSEcCtD
Oxymorphone—Pneumothorax—Epirubicin—liver cancer	0.0119	0.0172	CcSEcCtD
Oxymorphone—Pneumothorax—Doxorubicin—liver cancer	0.011	0.0159	CcSEcCtD
Oxymorphone—Dehydration—Sorafenib—liver cancer	0.0108	0.0156	CcSEcCtD
Oxymorphone—Weight decreased—Sorafenib—liver cancer	0.00907	0.0132	CcSEcCtD
Oxymorphone—Pneumonia—Sorafenib—liver cancer	0.00899	0.013	CcSEcCtD
Oxymorphone—Lung disorder—Epirubicin—liver cancer	0.00834	0.0121	CcSEcCtD
Oxymorphone—Ileus—Epirubicin—liver cancer	0.00834	0.0121	CcSEcCtD
Oxymorphone—Dermatitis atopic—Epirubicin—liver cancer	0.00797	0.0116	CcSEcCtD
Oxymorphone—Urinary tract disorder—Sorafenib—liver cancer	0.00792	0.0115	CcSEcCtD
Oxymorphone—Urethral disorder—Sorafenib—liver cancer	0.00786	0.0114	CcSEcCtD
Oxymorphone—Ileus—Doxorubicin—liver cancer	0.00772	0.0112	CcSEcCtD
Oxymorphone—Lung disorder—Doxorubicin—liver cancer	0.00772	0.0112	CcSEcCtD
Oxymorphone—Flushing—Sorafenib—liver cancer	0.00744	0.0108	CcSEcCtD
Oxymorphone—Cardiac disorder—Sorafenib—liver cancer	0.00744	0.0108	CcSEcCtD
Oxymorphone—Dermatitis atopic—Doxorubicin—liver cancer	0.00738	0.0107	CcSEcCtD
Oxymorphone—Angiopathy—Sorafenib—liver cancer	0.00728	0.0106	CcSEcCtD
Oxymorphone—Immune system disorder—Sorafenib—liver cancer	0.00724	0.0105	CcSEcCtD
Oxymorphone—Mediastinal disorder—Sorafenib—liver cancer	0.00723	0.0105	CcSEcCtD
Oxymorphone—Mental disorder—Sorafenib—liver cancer	0.00703	0.0102	CcSEcCtD
Oxymorphone—Malnutrition—Sorafenib—liver cancer	0.00698	0.0101	CcSEcCtD
Oxymorphone—Oliguria—Epirubicin—liver cancer	0.0064	0.0093	CcSEcCtD
Oxymorphone—Syncope—Sorafenib—liver cancer	0.00626	0.00909	CcSEcCtD
Oxymorphone—Loss of consciousness—Sorafenib—liver cancer	0.00614	0.00891	CcSEcCtD
Oxymorphone—Hypertension—Sorafenib—liver cancer	0.00603	0.00875	CcSEcCtD
Oxymorphone—Oliguria—Doxorubicin—liver cancer	0.00593	0.0086	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.0059	0.00857	CcSEcCtD
Oxymorphone—Injection site reaction—Epirubicin—liver cancer	0.00587	0.00852	CcSEcCtD
Oxymorphone—Dry mouth—Sorafenib—liver cancer	0.00581	0.00844	CcSEcCtD
Oxymorphone—Shock—Sorafenib—liver cancer	0.00561	0.00814	CcSEcCtD
Oxymorphone—Nervous system disorder—Sorafenib—liver cancer	0.00559	0.00811	CcSEcCtD
Oxymorphone—Skin disorder—Sorafenib—liver cancer	0.00553	0.00803	CcSEcCtD
Oxymorphone—Anorexia—Sorafenib—liver cancer	0.00543	0.00788	CcSEcCtD
Oxymorphone—Injection site reaction—Doxorubicin—liver cancer	0.00543	0.00788	CcSEcCtD
Oxymorphone—Mental disability—Epirubicin—liver cancer	0.00512	0.00743	CcSEcCtD
Oxymorphone—Dyspnoea—Sorafenib—liver cancer	0.00508	0.00737	CcSEcCtD
Oxymorphone—Dyspepsia—Sorafenib—liver cancer	0.00502	0.00728	CcSEcCtD
Oxymorphone—Decreased appetite—Sorafenib—liver cancer	0.00495	0.00719	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Sorafenib—liver cancer	0.00492	0.00714	CcSEcCtD
Oxymorphone—Fatigue—Sorafenib—liver cancer	0.00491	0.00713	CcSEcCtD
Oxymorphone—Constipation—Sorafenib—liver cancer	0.00487	0.00707	CcSEcCtD
Oxymorphone—Pain—Sorafenib—liver cancer	0.00487	0.00707	CcSEcCtD
Oxymorphone—Mental disability—Doxorubicin—liver cancer	0.00474	0.00688	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Sorafenib—liver cancer	0.00466	0.00676	CcSEcCtD
Oxymorphone—Hot flush—Epirubicin—liver cancer	0.00458	0.00665	CcSEcCtD
Oxymorphone—Menopausal symptoms—Epirubicin—liver cancer	0.00454	0.00659	CcSEcCtD
Oxymorphone—Urticaria—Sorafenib—liver cancer	0.00453	0.00657	CcSEcCtD
Oxymorphone—Abdominal pain—Sorafenib—liver cancer	0.0045	0.00654	CcSEcCtD
Oxymorphone—Body temperature increased—Sorafenib—liver cancer	0.0045	0.00654	CcSEcCtD
Oxymorphone—Lethargy—Epirubicin—liver cancer	0.00437	0.00635	CcSEcCtD
Oxymorphone—Diplopia—Epirubicin—liver cancer	0.00428	0.00622	CcSEcCtD
Oxymorphone—Hot flush—Doxorubicin—liver cancer	0.00424	0.00615	CcSEcCtD
Oxymorphone—Menopausal symptoms—Doxorubicin—liver cancer	0.0042	0.0061	CcSEcCtD
Oxymorphone—Hypersensitivity—Sorafenib—liver cancer	0.0042	0.00609	CcSEcCtD
Oxymorphone—Asthenia—Sorafenib—liver cancer	0.00409	0.00593	CcSEcCtD
Oxymorphone—Lethargy—Doxorubicin—liver cancer	0.00405	0.00587	CcSEcCtD
Oxymorphone—Pruritus—Sorafenib—liver cancer	0.00403	0.00585	CcSEcCtD
Oxymorphone—Dehydration—Epirubicin—liver cancer	0.00398	0.00578	CcSEcCtD
Oxymorphone—Diplopia—Doxorubicin—liver cancer	0.00396	0.00575	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Epirubicin—liver cancer	0.00391	0.00568	CcSEcCtD
Oxymorphone—Diarrhoea—Sorafenib—liver cancer	0.0039	0.00566	CcSEcCtD
Oxymorphone—Dizziness—Sorafenib—liver cancer	0.00377	0.00547	CcSEcCtD
Oxymorphone—Abdominal distension—Epirubicin—liver cancer	0.00373	0.00541	CcSEcCtD
Oxymorphone—Dehydration—Doxorubicin—liver cancer	0.00369	0.00535	CcSEcCtD
Oxymorphone—Vomiting—Sorafenib—liver cancer	0.00362	0.00526	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Doxorubicin—liver cancer	0.00362	0.00526	CcSEcCtD
Oxymorphone—Dermatitis—Sorafenib—liver cancer	0.00359	0.00521	CcSEcCtD
Oxymorphone—Headache—Sorafenib—liver cancer	0.00357	0.00518	CcSEcCtD
Oxymorphone—Abdominal distension—Doxorubicin—liver cancer	0.00345	0.00501	CcSEcCtD
Oxymorphone—Nausea—Sorafenib—liver cancer	0.00338	0.00491	CcSEcCtD
Oxymorphone—Weight decreased—Epirubicin—liver cancer	0.00335	0.00486	CcSEcCtD
Oxymorphone—Pneumonia—Epirubicin—liver cancer	0.00332	0.00482	CcSEcCtD
Oxymorphone—Weight decreased—Doxorubicin—liver cancer	0.0031	0.0045	CcSEcCtD
Oxymorphone—Pneumonia—Doxorubicin—liver cancer	0.00307	0.00446	CcSEcCtD
Oxymorphone—Bradycardia—Epirubicin—liver cancer	0.00302	0.00438	CcSEcCtD
Oxymorphone—Urinary tract disorder—Epirubicin—liver cancer	0.00293	0.00425	CcSEcCtD
Oxymorphone—Urethral disorder—Epirubicin—liver cancer	0.00291	0.00422	CcSEcCtD
Oxymorphone—Visual impairment—Epirubicin—liver cancer	0.00286	0.00415	CcSEcCtD
Oxymorphone—Bradycardia—Doxorubicin—liver cancer	0.00279	0.00405	CcSEcCtD
Oxymorphone—Eye disorder—Epirubicin—liver cancer	0.00277	0.00402	CcSEcCtD
Oxymorphone—Flushing—Epirubicin—liver cancer	0.00275	0.00399	CcSEcCtD
Oxymorphone—Cardiac disorder—Epirubicin—liver cancer	0.00275	0.00399	CcSEcCtD
Oxymorphone—Urinary tract disorder—Doxorubicin—liver cancer	0.00271	0.00393	CcSEcCtD
Oxymorphone—Angiopathy—Epirubicin—liver cancer	0.00269	0.0039	CcSEcCtD
Oxymorphone—Urethral disorder—Doxorubicin—liver cancer	0.00269	0.0039	CcSEcCtD
Oxymorphone—Immune system disorder—Epirubicin—liver cancer	0.00268	0.00389	CcSEcCtD
Oxymorphone—Mediastinal disorder—Epirubicin—liver cancer	0.00267	0.00388	CcSEcCtD
Oxymorphone—Visual impairment—Doxorubicin—liver cancer	0.00264	0.00384	CcSEcCtD
Oxymorphone—Mental disorder—Epirubicin—liver cancer	0.0026	0.00377	CcSEcCtD
Oxymorphone—Malnutrition—Epirubicin—liver cancer	0.00258	0.00374	CcSEcCtD
Oxymorphone—Eye disorder—Doxorubicin—liver cancer	0.00256	0.00372	CcSEcCtD
Oxymorphone—Cardiac disorder—Doxorubicin—liver cancer	0.00255	0.00369	CcSEcCtD
Oxymorphone—Flushing—Doxorubicin—liver cancer	0.00255	0.00369	CcSEcCtD
Oxymorphone—Flatulence—Epirubicin—liver cancer	0.00254	0.00369	CcSEcCtD
Oxymorphone—Tension—Epirubicin—liver cancer	0.00253	0.00367	CcSEcCtD
Oxymorphone—Nervousness—Epirubicin—liver cancer	0.00251	0.00364	CcSEcCtD
Oxymorphone—Angiopathy—Doxorubicin—liver cancer	0.00249	0.00361	CcSEcCtD
Oxymorphone—Immune system disorder—Doxorubicin—liver cancer	0.00248	0.0036	CcSEcCtD
Oxymorphone—Mediastinal disorder—Doxorubicin—liver cancer	0.00247	0.00359	CcSEcCtD
Oxymorphone—Naloxone—ESR1—liver cancer	0.00246	0.692	CrCbGaD
Oxymorphone—Vision blurred—Epirubicin—liver cancer	0.00243	0.00353	CcSEcCtD
Oxymorphone—Mental disorder—Doxorubicin—liver cancer	0.0024	0.00349	CcSEcCtD
Oxymorphone—Malnutrition—Doxorubicin—liver cancer	0.00239	0.00346	CcSEcCtD
Oxymorphone—Agitation—Epirubicin—liver cancer	0.00237	0.00344	CcSEcCtD
Oxymorphone—Flatulence—Doxorubicin—liver cancer	0.00235	0.00341	CcSEcCtD
Oxymorphone—Tension—Doxorubicin—liver cancer	0.00234	0.0034	CcSEcCtD
Oxymorphone—Nervousness—Doxorubicin—liver cancer	0.00232	0.00337	CcSEcCtD
Oxymorphone—Vertigo—Epirubicin—liver cancer	0.00232	0.00336	CcSEcCtD
Oxymorphone—Syncope—Epirubicin—liver cancer	0.00231	0.00336	CcSEcCtD
Oxymorphone—Palpitations—Epirubicin—liver cancer	0.00228	0.00331	CcSEcCtD
Oxymorphone—Loss of consciousness—Epirubicin—liver cancer	0.00227	0.00329	CcSEcCtD
Oxymorphone—Vision blurred—Doxorubicin—liver cancer	0.00225	0.00327	CcSEcCtD
Oxymorphone—Convulsion—Epirubicin—liver cancer	0.00224	0.00324	CcSEcCtD
Oxymorphone—Hypertension—Epirubicin—liver cancer	0.00223	0.00323	CcSEcCtD
Oxymorphone—Chest pain—Epirubicin—liver cancer	0.0022	0.00319	CcSEcCtD
Oxymorphone—Agitation—Doxorubicin—liver cancer	0.00219	0.00318	CcSEcCtD
Oxymorphone—Anxiety—Epirubicin—liver cancer	0.00219	0.00318	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00218	0.00317	CcSEcCtD
Oxymorphone—Dry mouth—Epirubicin—liver cancer	0.00215	0.00312	CcSEcCtD
Oxymorphone—Vertigo—Doxorubicin—liver cancer	0.00214	0.00311	CcSEcCtD
Oxymorphone—Syncope—Doxorubicin—liver cancer	0.00214	0.00311	CcSEcCtD
Oxymorphone—Confusional state—Epirubicin—liver cancer	0.00212	0.00308	CcSEcCtD
Oxymorphone—Palpitations—Doxorubicin—liver cancer	0.00211	0.00306	CcSEcCtD
Oxymorphone—Oedema—Epirubicin—liver cancer	0.00211	0.00306	CcSEcCtD
Oxymorphone—Loss of consciousness—Doxorubicin—liver cancer	0.0021	0.00305	CcSEcCtD
Oxymorphone—Shock—Epirubicin—liver cancer	0.00207	0.00301	CcSEcCtD
Oxymorphone—Convulsion—Doxorubicin—liver cancer	0.00207	0.003	CcSEcCtD
Oxymorphone—Nervous system disorder—Epirubicin—liver cancer	0.00207	0.003	CcSEcCtD
Oxymorphone—Hypertension—Doxorubicin—liver cancer	0.00206	0.00299	CcSEcCtD
Oxymorphone—Tachycardia—Epirubicin—liver cancer	0.00206	0.00298	CcSEcCtD
Oxymorphone—Skin disorder—Epirubicin—liver cancer	0.00205	0.00297	CcSEcCtD
Oxymorphone—Hyperhidrosis—Epirubicin—liver cancer	0.00204	0.00295	CcSEcCtD
Oxymorphone—Chest pain—Doxorubicin—liver cancer	0.00203	0.00295	CcSEcCtD
Oxymorphone—Anxiety—Doxorubicin—liver cancer	0.00203	0.00294	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00202	0.00293	CcSEcCtD
Oxymorphone—Anorexia—Epirubicin—liver cancer	0.00201	0.00291	CcSEcCtD
Oxymorphone—Dry mouth—Doxorubicin—liver cancer	0.00199	0.00289	CcSEcCtD
Oxymorphone—Hypotension—Epirubicin—liver cancer	0.00197	0.00286	CcSEcCtD
Oxymorphone—Confusional state—Doxorubicin—liver cancer	0.00196	0.00285	CcSEcCtD
Oxymorphone—Oedema—Doxorubicin—liver cancer	0.00195	0.00283	CcSEcCtD
Oxymorphone—Shock—Doxorubicin—liver cancer	0.00192	0.00278	CcSEcCtD
Oxymorphone—Nervous system disorder—Doxorubicin—liver cancer	0.00191	0.00277	CcSEcCtD
Oxymorphone—Insomnia—Epirubicin—liver cancer	0.0019	0.00276	CcSEcCtD
Oxymorphone—Tachycardia—Doxorubicin—liver cancer	0.0019	0.00276	CcSEcCtD
Oxymorphone—Skin disorder—Doxorubicin—liver cancer	0.00189	0.00275	CcSEcCtD
Oxymorphone—Hyperhidrosis—Doxorubicin—liver cancer	0.00188	0.00273	CcSEcCtD
Oxymorphone—Dyspnoea—Epirubicin—liver cancer	0.00188	0.00272	CcSEcCtD
Oxymorphone—Somnolence—Epirubicin—liver cancer	0.00187	0.00272	CcSEcCtD
Oxymorphone—Anorexia—Doxorubicin—liver cancer	0.00186	0.0027	CcSEcCtD
Oxymorphone—Dyspepsia—Epirubicin—liver cancer	0.00185	0.00269	CcSEcCtD
Oxymorphone—Decreased appetite—Epirubicin—liver cancer	0.00183	0.00266	CcSEcCtD
Oxymorphone—Hypotension—Doxorubicin—liver cancer	0.00182	0.00264	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Epirubicin—liver cancer	0.00182	0.00264	CcSEcCtD
Oxymorphone—Fatigue—Epirubicin—liver cancer	0.00182	0.00263	CcSEcCtD
Oxymorphone—Pain—Epirubicin—liver cancer	0.0018	0.00261	CcSEcCtD
Oxymorphone—Constipation—Epirubicin—liver cancer	0.0018	0.00261	CcSEcCtD
Oxymorphone—Insomnia—Doxorubicin—liver cancer	0.00176	0.00256	CcSEcCtD
Oxymorphone—Dyspnoea—Doxorubicin—liver cancer	0.00174	0.00252	CcSEcCtD
Oxymorphone—Feeling abnormal—Epirubicin—liver cancer	0.00174	0.00252	CcSEcCtD
Oxymorphone—Somnolence—Doxorubicin—liver cancer	0.00173	0.00251	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Epirubicin—liver cancer	0.00172	0.0025	CcSEcCtD
Oxymorphone—Dyspepsia—Doxorubicin—liver cancer	0.00172	0.00249	CcSEcCtD
Oxymorphone—Decreased appetite—Doxorubicin—liver cancer	0.00169	0.00246	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00168	0.00244	CcSEcCtD
Oxymorphone—Fatigue—Doxorubicin—liver cancer	0.00168	0.00244	CcSEcCtD
Oxymorphone—Urticaria—Epirubicin—liver cancer	0.00167	0.00243	CcSEcCtD
Oxymorphone—Pain—Doxorubicin—liver cancer	0.00167	0.00242	CcSEcCtD
Oxymorphone—Constipation—Doxorubicin—liver cancer	0.00167	0.00242	CcSEcCtD
Oxymorphone—Abdominal pain—Epirubicin—liver cancer	0.00166	0.00242	CcSEcCtD
Oxymorphone—Body temperature increased—Epirubicin—liver cancer	0.00166	0.00242	CcSEcCtD
Oxymorphone—Feeling abnormal—Doxorubicin—liver cancer	0.00161	0.00233	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Doxorubicin—liver cancer	0.00159	0.00231	CcSEcCtD
Oxymorphone—Hypersensitivity—Epirubicin—liver cancer	0.00155	0.00225	CcSEcCtD
Oxymorphone—Urticaria—Doxorubicin—liver cancer	0.00155	0.00225	CcSEcCtD
Oxymorphone—Abdominal pain—Doxorubicin—liver cancer	0.00154	0.00224	CcSEcCtD
Oxymorphone—Body temperature increased—Doxorubicin—liver cancer	0.00154	0.00224	CcSEcCtD
Oxymorphone—Asthenia—Epirubicin—liver cancer	0.00151	0.00219	CcSEcCtD
Oxymorphone—Pruritus—Epirubicin—liver cancer	0.00149	0.00216	CcSEcCtD
Oxymorphone—Diarrhoea—Epirubicin—liver cancer	0.00144	0.00209	CcSEcCtD
Oxymorphone—Hypersensitivity—Doxorubicin—liver cancer	0.00144	0.00208	CcSEcCtD
Oxymorphone—Asthenia—Doxorubicin—liver cancer	0.0014	0.00203	CcSEcCtD
Oxymorphone—Dizziness—Epirubicin—liver cancer	0.00139	0.00202	CcSEcCtD
Oxymorphone—Pruritus—Doxorubicin—liver cancer	0.00138	0.002	CcSEcCtD
Oxymorphone—Vomiting—Epirubicin—liver cancer	0.00134	0.00194	CcSEcCtD
Oxymorphone—Diarrhoea—Doxorubicin—liver cancer	0.00133	0.00193	CcSEcCtD
Oxymorphone—Dermatitis—Epirubicin—liver cancer	0.00133	0.00193	CcSEcCtD
Oxymorphone—Headache—Epirubicin—liver cancer	0.00132	0.00191	CcSEcCtD
Oxymorphone—Dizziness—Doxorubicin—liver cancer	0.00129	0.00187	CcSEcCtD
Oxymorphone—Nausea—Epirubicin—liver cancer	0.00125	0.00182	CcSEcCtD
Oxymorphone—Vomiting—Doxorubicin—liver cancer	0.00124	0.0018	CcSEcCtD
Oxymorphone—Dermatitis—Doxorubicin—liver cancer	0.00123	0.00178	CcSEcCtD
Oxymorphone—Headache—Doxorubicin—liver cancer	0.00122	0.00177	CcSEcCtD
Oxymorphone—Nausea—Doxorubicin—liver cancer	0.00116	0.00168	CcSEcCtD
Oxymorphone—Naloxone—ALB—liver cancer	0.0011	0.308	CrCbGaD
Oxymorphone—OPRM1—Signaling Pathways—FST—liver cancer	0.000138	0.00118	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PRKCE—liver cancer	0.000135	0.00116	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ADAM17—liver cancer	0.000135	0.00115	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—EPT1—liver cancer	0.000134	0.00114	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TRIO—liver cancer	0.000132	0.00112	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000131	0.00112	CbGpPWpGaD
Oxymorphone—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.00013	0.00111	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CSF2—liver cancer	0.000129	0.0011	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—TAT—liver cancer	0.000127	0.00109	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—F2—liver cancer	0.000127	0.00108	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PSMA4—liver cancer	0.000127	0.00108	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PSMD10—liver cancer	0.000127	0.00108	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCR4—liver cancer	0.000126	0.00108	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000125	0.00106	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PRKCE—liver cancer	0.000123	0.00105	CbGpPWpGaD
Oxymorphone—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000123	0.00105	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—PIK3CG—liver cancer	0.000121	0.00104	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CSF2—liver cancer	0.00012	0.00102	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ADAM17—liver cancer	0.000118	0.00101	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—F2—liver cancer	0.000115	0.000984	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—F2—liver cancer	0.000111	0.000951	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PSMA4—liver cancer	0.000111	0.000948	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PSMD10—liver cancer	0.000111	0.000948	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PIK3CG—liver cancer	0.00011	0.000942	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CSF2—liver cancer	0.000109	0.00093	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—PIK3CD—liver cancer	0.000107	0.000912	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PIK3CG—liver cancer	0.000106	0.00091	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—F2—liver cancer	0.000101	0.000863	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ADAM17—liver cancer	9.98e-05	0.000852	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PRKCE—liver cancer	9.81e-05	0.000838	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PIK3CD—liver cancer	9.69e-05	0.000828	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PIK3CG—liver cancer	9.67e-05	0.000826	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—F2—liver cancer	9.4e-05	0.000803	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PSMD10—liver cancer	9.38e-05	0.000801	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PSMA4—liver cancer	9.38e-05	0.000801	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PIK3CD—liver cancer	9.36e-05	0.0008	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—UGDH—liver cancer	9.32e-05	0.000796	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—PIK3CB—liver cancer	9.31e-05	0.000795	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IGF2—liver cancer	9.29e-05	0.000794	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PIK3CG—liver cancer	9e-05	0.000769	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—EPT1—liver cancer	8.76e-05	0.000748	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CSF2—liver cancer	8.67e-05	0.000741	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—RAF1—liver cancer	8.65e-05	0.000739	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CPT1B—liver cancer	8.63e-05	0.000738	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GLUL—liver cancer	8.63e-05	0.000738	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PRKCE—liver cancer	8.6e-05	0.000735	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—H2AFX—liver cancer	8.55e-05	0.00073	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—IL2—liver cancer	8.55e-05	0.00073	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—F2—liver cancer	8.54e-05	0.00073	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PIK3CD—liver cancer	8.5e-05	0.000726	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PIK3CB—liver cancer	8.45e-05	0.000722	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NR1H4—liver cancer	8.33e-05	0.000711	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—TAT—liver cancer	8.3e-05	0.00071	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTA3—liver cancer	8.19e-05	0.000699	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3CG—liver cancer	8.17e-05	0.000698	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PIK3CB—liver cancer	8.16e-05	0.000697	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IGF2—liver cancer	8.15e-05	0.000696	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PIK3CD—liver cancer	7.91e-05	0.000676	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL2—liver cancer	7.76e-05	0.000663	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TERT—liver cancer	7.73e-05	0.000661	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CSF2—liver cancer	7.61e-05	0.00065	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—RAF1—liver cancer	7.59e-05	0.000648	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—H2AFX—liver cancer	7.5e-05	0.00064	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—IL2—liver cancer	7.49e-05	0.00064	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTA4—liver cancer	7.49e-05	0.00064	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PIK3CB—liver cancer	7.41e-05	0.000633	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTA2—liver cancer	7.3e-05	0.000623	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PRKCE—liver cancer	7.27e-05	0.000621	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3CD—liver cancer	7.18e-05	0.000614	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—KDR—liver cancer	7.07e-05	0.000604	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTA1—liver cancer	7.04e-05	0.000601	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MAPK14—liver cancer	7.03e-05	0.0006	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NAT2—liver cancer	6.96e-05	0.000595	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PIK3CB—liver cancer	6.9e-05	0.000589	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ESR1—liver cancer	6.89e-05	0.000589	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IGF2—liver cancer	6.88e-05	0.000588	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—F2—liver cancer	6.81e-05	0.000582	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL2—liver cancer	6.8e-05	0.000581	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TERT—liver cancer	6.78e-05	0.000579	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALDOB—liver cancer	6.67e-05	0.00057	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—APC—liver cancer	6.51e-05	0.000557	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CG—liver cancer	6.51e-05	0.000557	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CSF2—liver cancer	6.43e-05	0.000549	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—RAF1—liver cancer	6.41e-05	0.000548	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CRABP1—liver cancer	6.37e-05	0.000544	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—H2AFX—liver cancer	6.34e-05	0.000541	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—IL2—liver cancer	6.33e-05	0.000541	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3CB—liver cancer	6.26e-05	0.000535	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KDR—liver cancer	6.2e-05	0.00053	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAPK14—liver cancer	6.16e-05	0.000526	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—BRAF—liver cancer	6.12e-05	0.000523	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ESR1—liver cancer	6.04e-05	0.000516	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—F2—liver cancer	5.97e-05	0.00051	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL2—liver cancer	5.75e-05	0.000491	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TERT—liver cancer	5.73e-05	0.00049	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CD—liver cancer	5.73e-05	0.000489	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CG—liver cancer	5.71e-05	0.000488	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—APC—liver cancer	5.71e-05	0.000488	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—PIK3CA—liver cancer	5.67e-05	0.000485	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SERPINE1—liver cancer	5.66e-05	0.000484	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CPT1B—liver cancer	5.65e-05	0.000482	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GLUL—liver cancer	5.65e-05	0.000482	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—KRAS—liver cancer	5.61e-05	0.000479	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HPGDS—liver cancer	5.56e-05	0.000475	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NR1H4—liver cancer	5.44e-05	0.000465	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—BRAF—liver cancer	5.37e-05	0.000459	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTA3—liver cancer	5.35e-05	0.000457	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KDR—liver cancer	5.24e-05	0.000448	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAPK14—liver cancer	5.21e-05	0.000445	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PIK3CA—liver cancer	5.15e-05	0.00044	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—RAF1—liver cancer	5.11e-05	0.000437	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ESR1—liver cancer	5.11e-05	0.000436	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—F2—liver cancer	5.04e-05	0.000431	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CD—liver cancer	5.02e-05	0.000429	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CB—liver cancer	4.99e-05	0.000426	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MTOR—liver cancer	4.99e-05	0.000426	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PIK3CA—liver cancer	4.97e-05	0.000425	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SERPINE1—liver cancer	4.97e-05	0.000424	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PSMA4—liver cancer	4.96e-05	0.000424	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PSMD10—liver cancer	4.96e-05	0.000424	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—KRAS—liver cancer	4.92e-05	0.00042	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTA4—liver cancer	4.89e-05	0.000418	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—APC—liver cancer	4.83e-05	0.000412	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CG—liver cancer	4.83e-05	0.000412	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GOT2—liver cancer	4.82e-05	0.000412	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTA2—liver cancer	4.77e-05	0.000408	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—HRAS—liver cancer	4.77e-05	0.000407	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CDKN1B—liver cancer	4.68e-05	0.0004	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—AKT1—liver cancer	4.63e-05	0.000396	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTA1—liver cancer	4.6e-05	0.000393	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CASP3—liver cancer	4.59e-05	0.000392	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL2—liver cancer	4.58e-05	0.000392	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL6—liver cancer	4.56e-05	0.00039	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NAT2—liver cancer	4.55e-05	0.000389	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—BRAF—liver cancer	4.54e-05	0.000388	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP2E1—liver cancer	4.54e-05	0.000388	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PIK3CA—liver cancer	4.52e-05	0.000386	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—RAF1—liver cancer	4.48e-05	0.000383	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCND1—liver cancer	4.47e-05	0.000382	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—JUN—liver cancer	4.46e-05	0.000381	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CTNNB1—liver cancer	4.43e-05	0.000378	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MTOR—liver cancer	4.38e-05	0.000374	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CB—liver cancer	4.38e-05	0.000374	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALDOB—liver cancer	4.36e-05	0.000373	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MMP9—liver cancer	4.34e-05	0.000371	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CDKN1A—liver cancer	4.32e-05	0.000369	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CD—liver cancer	4.24e-05	0.000363	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYCS—liver cancer	4.24e-05	0.000363	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MAPK8—liver cancer	4.22e-05	0.000361	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—AKT1—liver cancer	4.21e-05	0.00036	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PIK3CA—liver cancer	4.2e-05	0.000359	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SERPINE1—liver cancer	4.2e-05	0.000359	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—HRAS—liver cancer	4.18e-05	0.000357	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GOT1—liver cancer	4.16e-05	0.000356	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GGT1—liver cancer	4.16e-05	0.000356	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CRABP1—liver cancer	4.16e-05	0.000356	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—KRAS—liver cancer	4.16e-05	0.000355	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CDKN1B—liver cancer	4.11e-05	0.000351	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—AKT1—liver cancer	4.06e-05	0.000347	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CASP3—liver cancer	4.03e-05	0.000344	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL2—liver cancer	4.02e-05	0.000343	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL6—liver cancer	4e-05	0.000342	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCND1—liver cancer	3.92e-05	0.000335	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—JUN—liver cancer	3.91e-05	0.000334	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—VEGFA—liver cancer	3.9e-05	0.000333	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CTNNB1—liver cancer	3.88e-05	0.000332	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—STAT3—liver cancer	3.86e-05	0.00033	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3CA—liver cancer	3.82e-05	0.000326	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MMP9—liver cancer	3.8e-05	0.000325	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CDKN1A—liver cancer	3.79e-05	0.000324	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—RAF1—liver cancer	3.79e-05	0.000324	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTP1—liver cancer	3.74e-05	0.00032	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAPK8—liver cancer	3.7e-05	0.000316	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CB—liver cancer	3.7e-05	0.000316	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MTOR—liver cancer	3.7e-05	0.000316	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—AKT1—liver cancer	3.69e-05	0.000315	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HMOX1—liver cancer	3.69e-05	0.000315	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HPGDS—liver cancer	3.64e-05	0.000311	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MYC—liver cancer	3.58e-05	0.000306	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TGFB1—liver cancer	3.58e-05	0.000306	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—HRAS—liver cancer	3.53e-05	0.000302	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CDKN1B—liver cancer	3.47e-05	0.000297	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTM1—liver cancer	3.44e-05	0.000294	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—AKT1—liver cancer	3.43e-05	0.000293	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—VEGFA—liver cancer	3.42e-05	0.000292	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CASP3—liver cancer	3.4e-05	0.000291	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL2—liver cancer	3.4e-05	0.00029	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—STAT3—liver cancer	3.38e-05	0.000289	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL6—liver cancer	3.38e-05	0.000289	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—KRAS—liver cancer	3.31e-05	0.000283	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCND1—liver cancer	3.31e-05	0.000283	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—JUN—liver cancer	3.3e-05	0.000282	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CTNNB1—liver cancer	3.28e-05	0.00028	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP1A1—liver cancer	3.26e-05	0.000278	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PSMA4—liver cancer	3.24e-05	0.000277	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PSMD10—liver cancer	3.24e-05	0.000277	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MMP9—liver cancer	3.22e-05	0.000275	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CDKN1A—liver cancer	3.2e-05	0.000274	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GOT2—liver cancer	3.15e-05	0.000269	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MYC—liver cancer	3.14e-05	0.000269	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TGFB1—liver cancer	3.14e-05	0.000268	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAPK8—liver cancer	3.13e-05	0.000267	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—AKT1—liver cancer	3.12e-05	0.000266	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CA—liver cancer	3.04e-05	0.00026	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—MTHFR—liver cancer	3.04e-05	0.00026	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PPARA—liver cancer	2.98e-05	0.000255	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP2E1—liver cancer	2.97e-05	0.000253	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TP53—liver cancer	2.94e-05	0.000252	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KRAS—liver cancer	2.9e-05	0.000248	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—VEGFA—liver cancer	2.89e-05	0.000247	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—STAT3—liver cancer	2.86e-05	0.000244	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HRAS—liver cancer	2.82e-05	0.000241	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYCS—liver cancer	2.77e-05	0.000237	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GGT1—liver cancer	2.72e-05	0.000233	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GOT1—liver cancer	2.72e-05	0.000233	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL6—liver cancer	2.69e-05	0.00023	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CA—liver cancer	2.67e-05	0.000228	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MYC—liver cancer	2.66e-05	0.000227	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TGFB1—liver cancer	2.65e-05	0.000226	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TP53—liver cancer	2.58e-05	0.000221	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CG—liver cancer	2.55e-05	0.000218	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—AKT1—liver cancer	2.49e-05	0.000212	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HRAS—liver cancer	2.47e-05	0.000211	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PPARG—liver cancer	2.46e-05	0.00021	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KRAS—liver cancer	2.45e-05	0.00021	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTP1—liver cancer	2.45e-05	0.000209	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HMOX1—liver cancer	2.41e-05	0.000206	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL6—liver cancer	2.36e-05	0.000202	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CA—liver cancer	2.26e-05	0.000193	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTM1—liver cancer	2.25e-05	0.000192	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CD—liver cancer	2.24e-05	0.000192	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALB—liver cancer	2.22e-05	0.000189	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TP53—liver cancer	2.18e-05	0.000186	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AKT1—liver cancer	2.18e-05	0.000186	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP1A1—liver cancer	2.13e-05	0.000182	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HRAS—liver cancer	2.09e-05	0.000178	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL6—liver cancer	2e-05	0.000171	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MTHFR—liver cancer	1.99e-05	0.00017	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CB—liver cancer	1.96e-05	0.000167	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PPARA—liver cancer	1.95e-05	0.000166	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AKT1—liver cancer	1.84e-05	0.000157	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CG—liver cancer	1.67e-05	0.000143	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PPARG—liver cancer	1.61e-05	0.000138	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CD—liver cancer	1.47e-05	0.000125	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALB—liver cancer	1.45e-05	0.000124	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CB—liver cancer	1.28e-05	0.000109	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CA—liver cancer	1.19e-05	0.000102	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—AKT1—liver cancer	9.74e-06	8.32e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CA—liver cancer	7.79e-06	6.66e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—AKT1—liver cancer	6.37e-06	5.44e-05	CbGpPWpGaD
